Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	67.66	84.72	111.27	159.52	334.43	326.18
Short-Term Investments	41.82	68.07	112.36	184.42	7.44	7.53
Cash & Short-Term Investments	109.47	152.79	223.63	343.94	341.87	333.71
Cash Growth	-47.40%	-31.68%	-34.98%	0.61%	2.44%	252.03%
Accounts Receivable	0.42	0.93	1.13	1.53	-	-
Other Receivables	14.2	11.42	14.18	2.8	3.23	6.16
Receivables	14.62	12.35	15.31	4.32	3.23	6.16
Prepaid Expenses	2.48	6.01	4.75	5.72	6.31	6.68
Total Current Assets	126.57	171.15	243.69	353.98	351.41	346.55
Property, Plant & Equipment	0.7	4.22	7.54	9.6	13.1	8.62
Long-Term Deferred Tax Assets	-	-	-	-	3.62	1.41
Other Long-Term Assets	1.63	1.14	2.67	0.5	0.59	0.5
Total Assets	130.49	176.51	253.9	364.08	368.72	357.09
Accounts Payable	4.01	3.62	2.4	0.46	2.3	2.25
Accrued Expenses	11.87	19.65	23.86	21.37	16.53	5.79
Current Portion of Leases	0.65	1.85	2.4	2.17	1.72	0.7
Current Income Taxes Payable	-	-	-	1.24	0.52	0.02
Current Unearned Revenue	-	-	10.22	53.1	11.92	2.07
Other Current Liabilities	3.56	0.17	0.19	0.27	2.1	0.18
Total Current Liabilities	20.09	25.29	39.08	78.62	35.09	11.01
Long-Term Leases	-	0.09	1.01	3.26	5.59	3.31
Long-Term Unearned Revenue	-	-	1.73	2.68	39.61	55.93
Total Liabilities	20.09	25.38	41.82	84.56	80.29	70.26
Common Stock	490.43	486.67	483.35	482.03	480.7	384.31
Additional Paid-In Capital	84.53	82.19	61.81	37.23	17.99	5.88
Retained Earnings	-464.59	-417.8	-333.11	-239.31	-210.27	-103.36
Comprehensive Income & Other	0.04	0.06	0.03	-0.43	-	-
Total Common Equity	110.41	151.13	212.08	279.52	288.42	286.83
Shareholders' Equity	110.41	151.13	212.08	279.52	288.42	286.83
Total Liabilities & Equity	130.49	176.51	253.9	364.08	368.72	357.09
Total Debt	0.65	1.93	3.41	5.43	7.31	4.01
Net Cash (Debt)	108.82	150.86	220.22	338.51	334.55	329.71
Net Cash Growth	-47.16%	-31.50%	-34.95%	1.18%	1.47%	251.75%
Net Cash Per Share	2.55	3.56	5.23	8.07	8.85	16.45
Filing Date Shares Outstanding	42.96	42.51	42.18	42.08	41.87	36.9
Total Common Shares Outstanding	42.96	42.51	42.18	42.04	41.85	36.9
Working Capital	106.49	145.86	204.61	275.36	316.33	335.54
Book Value Per Share	2.57	3.56	5.03	6.65	6.89	7.77
Tangible Book Value	110.41	151.13	212.08	279.52	288.42	286.83
Tangible Book Value Per Share	2.57	3.56	5.03	6.65	6.89	7.77
Machinery	-	8.95	8.97	7.06	6.51	5.24
Leasehold Improvements	-	2.55	2.55	2.52	2.47	0.71

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q